Clinical Role - Specialty Pharmacy
Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.
Oral Relugolix Shows Similar Rate of Castration Resistance-free Survival to IV Leuprolide Acetate in Advanced Prostate Cancer
The results of an additional secondary endpoint from the phase 3 HERO study evaluating oral relugolix in men with advanced prostate cancer showed that relugolix had a similar rate of castration resistance-free survival compared to intravenous leuprolide acetate in men with metastatic disease through 48 weeks.
The FDA has approved mepolizumab for the treatment of hypereosinophilic syndrome.
When an out-of-state specialty pharmacy distributes medications to residents of a state that has enacted a legend drug tax, is that out-of-state vendor subject to the 2% tax assessment?
Address the risks in policies and procedures to ensure that all employees are on the same page.
Pregnancy may help put off the onset of multiple sclerosis symptoms by more than 3 years.
Using a 3D model, investigators found a soy-based compound was effective in treating bone cancer.
At ESMO 2020, researchers discussed some long-awaited data regarding postoperative radiotherapy used in patients with non-small cell lung cancer following complete resection and after (neo) adjuvant chemotherapy.
New drug application been submitted for TLX591-CDx (illumet), a radiopharmaceutical product that targets prostate-specific membrane antigen for the imaging of prostate cancer.
No Survival Improvement From Radical Hysterectomy in Patients With Cervical Cancer, Intraoperative Detection of Positive Lymph Node Involvement
Among patients with cervical cancer, there was no significant difference found between the risk of recurrence, local recurrence, or death among individuals who either completed or abandoned a radical uterine procedure following the intraoperative detection of a positive pelvic lymph node.
Top news of the week from Pharmacy Times®.
The FDA has granted fast track designation to DKN-01 for the treatment of patients with gastric and gastroesophageal junction adenocarcinoma whose tumors have high DKK1 expression.
An overview of the most common human resources problems that pharmacies face and the proactive steps that pharmacies can take to avoid these problems.